Saturday, July 5, 2025 7/5/2025

COVID-19 Testing and Linkage to Care with African American Church and Health Agency Partners

Award Number: R01DK124664
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/01/2021
PERIOD OF PERFORMANCE END DATE: 12/31/2023

Group Awards By:

View Award Description

COVID-19 Testing and Linkage to Care with African American Church and Health Agency Partners - PROJECT SUMMARY African Americans (AA) are disproportionately burdened by COVID19 across the spectrum of related cases, hospitalizations, and deaths compared to Whites. Many multilayered barriers increase risk for COVID19 among AA including poverty, essential jobs with increased virus exposure, cultural norms (eg, risk denial, medical/contact tracing mistrust), and limited access to healthcare and other services/resources. These barriers highlight the need for accessible, trusted COVID19 testing and linkage to care (LTC) services (eg, health, prevention programs, community resources, contact tracing) to help slow COVID19 spread in AA communities. The AA church is an institution with extensive influence in AA communities and may be an ideal setting for increasing reach of COVID19 testing and LTC in hard hit AA communities. Yet, no controlled AA church-based studies exist on COVID19 testing interventions. The primary aim of this study is to fully test a culturally/religiously-tailored, church-based COVID19 testing and LTC intervention condition against a non- tailored intervention condition on COVID19 testing rates at 6 months with adult AA church members and the community members they serve. Churches will be matched on membership size, denomination and past participation in church health intervention studies, then randomized to treatment condition. Sixteen churches (8 churches/arm; 45 church and 15 community members/church; N=960 total) will participate in the study. LTC use, contact tracing approval, and COVID19 prevention behaviors will also be examined at 6 months as secondary outcomes. Guided by the Theory of Planned Behavior and Socioecological Model, our community- engaged approach includes trained church leaders delivering a culturally, church-appropriate COVID19 Toolkit inclusive of digital tools: a) individual self-help materials and tailored text messages; b) in-person/virtual group seminars for caregivers of persons with COVID19; c) in-person/virtual church services with COVID19 related materials/activities (e.g., sermons, testimonials, responsive readings); and d) church-community level LTC services (eg, insurance, healthcare, prevention programs, community resources, contact tracing) provided virtually by community health workers, church-community-based re-opening guidelines, and church-based COVID19 testing events with health agencies. Examination of LTC use and contact tracing approval will aid in understanding intervention impact on COVID19 testing by addressing participant essential needs. Potential mediators/moderators related to receipt of COVID-19 testing will be evaluated, and a process evaluation to determine implementation facilitators, barriers, and fidelity related to increasing COVID19 testing rates. Our ongoing meetings with our long-term faith and health partners is enabling us to quickly adapt our AA church- based HIV testing and diabetes prevention interventions for the proposed study. This multilevel study could provide an effective, scalable model for increasing COVID19 testing, prevention, and LTC/contact tracing approval with AA churches in partnership with health agencies, and provide strategies to streamline delivery/uptake of future COVID-19 vaccination.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2021	THE CURATORS OF THE UNIVERSITY OF MISSOURI	118 UNIVERSITY HALL	COLUMBIA	MO	65211	BOONE	USA	Trans-NIH Research Support	000	1	2/13/2025	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $626,758 )
2024	2024	THE CURATORS OF THE UNIVERSITY OF MISSOURI	118 UNIVERSITY HALL	COLUMBIA	MO	65211	BOONE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	5	7/5/2024	NON-COMPETING CONTINUATION	$626,758
2024	2022	UNIVERSITY OF MISSOURI SYSTEM	1011 E 51ST ST	KANSAS CITY	MO	64110	JACKSON	USA	Trans-NIH Research Support	000	2	2/9/2024	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $626,758

Issue Date FY: 2023 ( Subtotal = $661,274 )
2023	2023	UNIVERSITY OF MISSOURI SYSTEM	1011 E 51ST ST	KANSAS CITY	MO	64110	JACKSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	002	4	4/17/2023	NON-COMPETING CONTINUATION	$661,274
2023	2022	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Trans-NIH Research Support	000	2	1/12/2023	SUPPLEMENT FOR EXPANSION	$0
2023	2021	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Trans-NIH Research Support	001	1	2/8/2023	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $661,274

Issue Date FY: 2022 ( Subtotal = $1,117,911 )
2022	2022	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Trans-NIH Research Support	000	2	1/29/2022	SUPPLEMENT FOR EXPANSION	$454,524
2022	2022	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	3	4/5/2022	NON-COMPETING CONTINUATION	$663,387
2022	2021	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Trans-NIH Research Support	002	1	9/2/2022	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $1,117,911

Issue Date FY: 2021 ( Subtotal = $2,110,891 )
2021	2021	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Trans-NIH Research Support	003	1	3/31/2021	SUPPLEMENT FOR EXPANSION	$0
2021	2021	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Trans-NIH Research Support	001	1	12/10/2020	SUPPLEMENT FOR EXPANSION	$0
2021	2021	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	004	2	8/4/2021	NON-COMPETING CONTINUATION	$0
2021	2021	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	002	2	3/31/2021	NON-COMPETING CONTINUATION	$671,214
2021	2021	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Trans-NIH Research Support	000	1	11/17/2020	SUPPLEMENT FOR EXPANSION	$1,439,677
														Subtotal = $2,110,891

Issue Date FY: 2020 ( Subtotal = $686,578 )
2020	2020	UNIVERSITY OF MISSOURI SYSTEM	5100 ROCKHILL RD	KANSAS CITY	MO	64110	JACKSON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	3/17/2020	NEW	$686,578
														Subtotal = $686,578

Grand Total All Awards = $5,203,412

Top

All Categories

About

Search

Reports

Data Submission

Award Information

COVID-19 Testing and Linkage to Care with African American Church and Health Agency Partners

Award Number: R01DK124664

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/01/2021

PERIOD OF PERFORMANCE END DATE: 12/31/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer